PB

Pressure Biosciences IncOOTC PBIO Stock Report

Last reporting period 31 Mar, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

OOTC - OTC

PBIO Stock Analysis

PB

Uncovered

Pressure Biosciences Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-40/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

11.128 B

Pressure BioSciences, Inc. engages in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. The company is headquartered in South Easton, Massachusetts. The Company’s products include Barocyclers, Barocycler Accessories, External Pressure Calibration Device Kit, MicroTubes for Barocyclers, BaroShear K45, HUB High Pressure Generators and Accessories, HP Cell From ISS and RF1700 Mini Ultra-High Pressure Pump. The firm's solutions are based on the properties of both constant and alternating, pressure cycling technology (PCT) hydrostatic pressure. Its PCT is an enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to reproducibly control bio-molecular interactions. Its primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications.

View Section: Eyestock Rating